BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 15557508)

  • 41. [Effect of apolipoprotein E genotype on magnetic resonance spectrum in amnestic mild cognitive impairment and Alzheimer's disease patients].
    Zhu XQ; Zhou X; Zhao W; Zhang YM; Liu FJ; Cao J; Sun ZW
    Zhonghua Yi Xue Za Zhi; 2019 Apr; 99(15):1156-1161. PubMed ID: 31006219
    [No Abstract]   [Full Text] [Related]  

  • 42. Apolipoprotein E epsilon4 allele, temporal lobe atrophy, and white matter lesions in late-life dementias.
    Barber R; Gholkar A; Scheltens P; Ballard C; McKeith IG; Morris CM; O'Brien JT
    Arch Neurol; 1999 Aug; 56(8):961-5. PubMed ID: 10448801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Early- versus late-onset Alzheimer's disease in clinical practice: cognitive and global outcomes over 3 years.
    Wattmo C; Wallin ÅK
    Alzheimers Res Ther; 2017 Aug; 9(1):70. PubMed ID: 28859660
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Racial differences in the effect of APOE-ε4 genotypes on trail making test B in Alzheimer's disease: A longitudinal study.
    Xu C; Acevedo P; Lu Y; Su BB; Ozuna K; Padilla V; Karithara A; Mao C; Navia RO; Piamjariyakul U; Wang K;
    Int J Geriatr Psychiatry; 2023 Dec; 38(12):e6037. PubMed ID: 38100638
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apolipoprotein E alleles in Cuban patients with mild cognitive impairment.
    Suárez VM; Fernández Y; López Edel C; Clarke DH; Bobes MA; Riverón AM; López-Cánovas L
    Am J Alzheimers Dis Other Demen; 2014 May; 29(3):236-41. PubMed ID: 24370622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Higher Peripheral TREM2 mRNA Levels Relate to Cognitive Deficits and Hippocampal Atrophy in Alzheimer's Disease and Amnestic Mild Cognitive Impairment.
    Tan YJ; Ng ASL; Vipin A; Lim JKW; Chander RJ; Ji F; Qiu Y; Ting SKS; Hameed S; Lee TS; Zeng L; Kandiah N; Zhou J
    J Alzheimers Dis; 2017; 58(2):413-423. PubMed ID: 28453482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. APOE genotype: no influence on galantamine treatment efficacy nor on rate of decline in Alzheimer's disease.
    Aerssens J; Raeymaekers P; Lilienfeld S; Geerts H; Konings F; Parys W
    Dement Geriatr Cogn Disord; 2001; 12(2):69-77. PubMed ID: 11173877
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
    Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
    Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease.
    Velayudhan L; Proitsi P; Westman E; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Hodges A; Powell J; Lovestone S; Simmons A;
    J Alzheimers Dis; 2013; 33(3):755-66. PubMed ID: 23047370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. APOE ε4 worsens hippocampal CA1 apical neuropil atrophy and episodic memory.
    Kerchner GA; Berdnik D; Shen JC; Bernstein JD; Fenesy MC; Deutsch GK; Wyss-Coray T; Rutt BK
    Neurology; 2014 Feb; 82(8):691-7. PubMed ID: 24453080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Accelerated memory decline in Alzheimer's disease with apolipoprotein epsilon4 allele.
    Hirono N; Hashimoto M; Yasuda M; Kazui H; Mori E
    J Neuropsychiatry Clin Neurosci; 2003; 15(3):354-8. PubMed ID: 12928512
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.
    Hashimoto M; Yasuda M; Tanimukai S; Matsui M; Hirono N; Kazui H; Mori E
    Neurology; 2001 Oct; 57(8):1461-6. PubMed ID: 11673590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cerebral atrophy, apolipoprotein E varepsilon4, and rate of decline in everyday function among patients with amnestic mild cognitive impairment.
    Okonkwo OC; Alosco ML; Jerskey BA; Sweet LH; Ott BR; Tremont G;
    Alzheimers Dement; 2010 Sep; 6(5):404-11. PubMed ID: 20813341
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Patterns of cognitive impairment and apolipoprotein genotype in persons with Alzheimer's disease].
    Łuczywek E; Pffefer A; Nowicka A; Czyzewski K; ŁaŁowski M; Styczyńska M; Barcikowska M
    Neurol Neurochir Pol; 2001; 35(6):1021-33. PubMed ID: 11987699
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of APOE status on cognitive maintenance in healthy elderly persons.
    Zehnder AE; Bläsi S; Berres M; Monsch AU; Stähelin HB; Spiegel R
    Int J Geriatr Psychiatry; 2009 Feb; 24(2):132-41. PubMed ID: 18615849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The relation of regional cerebral perfusion and atrophy in mild cognitive impairment (MCI) and early Alzheimer's dementia.
    Luckhaus C; Cohnen M; Flüss MO; Jänner M; Grass-Kapanke B; Teipel SJ; Grothe M; Hampel H; Peters O; Kornhuber J; Maier W; Supprian T; Gaebel W; Mödder U; Wittsack HJ
    Psychiatry Res; 2010 Jul; 183(1):44-51. PubMed ID: 20541374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower cognitive performance of older football players possessing apolipoprotein E epsilon4.
    Kutner KC; Erlanger DM; Tsai J; Jordan B; Relkin NR
    Neurosurgery; 2000 Sep; 47(3):651-7; discussion 657-8. PubMed ID: 10981753
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Apolipoprotein epsilon4 allele status, depressive symptoms, and cognitive decline in middle-aged and elderly persons without dementia.
    Lavretsky H; Ercoli L; Siddarth P; Bookheimer S; Miller K; Small G
    Am J Geriatr Psychiatry; 2003; 11(6):667-73. PubMed ID: 14609807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.